Neurol. praxi. 2014;15(1):47-51

Practical experience with zonisamide in childhood and adolescence

MUDr. Michal Ryzí, doc. MUDr. Hana Ošlejšková, Ph.D.
Klinika dětské neurologie LF MU a FN Brno

In comparison with adults approved options of antiepileptic treatment in children are limited. The process of introduction of new antiepileptic drug is often longer. The aim of this review is to present comprehensive information concerning zonisamide in new indication – add-on therapy of partial seizures in children older than 6 years. The results of multicentric, double blind, placebo controled study and results of open label studies about safety and tolerability are presented. These findings are accompanied by authors´ experience.

Keywords: zonisamide, partial seizures, epilepsy, indication in children, safety, tolerability

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryzí M, Ošlejšková H. Practical experience with zonisamide in childhood and adolescence. Neurol. praxi. 2014;15(1):47-51.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005; 46(1): 31-41. Go to original source... Go to PubMed...
    2. Faught E, Ayala R, Montouris GG, Leppik IE. Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001; 57(10): 1774-1779. Go to original source... Go to PubMed...
    3. Forsgren L, Beghi E, Oun A, Sillanpää M. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005; 12(4): 245-253. Go to original source... Go to PubMed...
    4. Glauser TA, Pellock JM. Zonisamide in pediatric epilepsy: review of the Japanese experience. J Child Neurol 2002; 17(2): 87-96. Go to original source... Go to PubMed...
    5. Guerrini R, Rosati A, Segieth J, Pellacani S, Bradshaw K, Giorgi L. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy. Epilepsia 2013; 54(8): 1473-1480. Go to original source... Go to PubMed...
    6. Ijff DM, Aldenkamp AP. Cognitive side-effects of antiepileptic drugs in children.Handb Clin Neurol 2013; 111: 707-718. Go to original source... Go to PubMed...
    7. Kluger G, Zsoter A, Holthausen H. Long-term use of zonisamide in refractory childhood-onset epilepsy. Eur J Paediatr Neurol 2008; 12 (1): 19-23. Go to original source... Go to PubMed...
    8. Lee YJ, Kang HC, Seo JH, Lee JS, Kim HD. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Brain Dev 2010; 32(3): 208-212. Go to original source... Go to PubMed...
    9. Leppik IE. Zonisamide: chemistry, mechanism of action and pharmacokinetics. Seizure 2004; 13 (Suppl 1): S5-9. Go to original source... Go to PubMed...
    10. Lotze TE, Wilfong AA. Zonisamide treatment for symptomatic infantile spasms. Neurology 2004;62 (2): 296-8. Low PA, James S, Peschel T, Leong R, Rothstein A.Zonisamide and associated oligohidrosis and hyperthermia. Epilepsy Res 2004; 62 (1): 27-34. Go to original source... Go to PubMed...
    11. Minami T, Ieiri I, Ohtsubo K, Hirakawa Y, Ueda K, Higuchi S, Aoyama T. Influence of additional therapy with zonisamide (Excegran) on protein binding and metabolism of carbamazepine. Epilepsia 1994; 35 (5): 1023-5. Go to original source... Go to PubMed...
    12. Odani A, Hashimoto Y, Takayanagi K, Otsuki Y, Koue T, Takano M, Yasuhara M, Hattori H, Furusho K, Inui K. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model. Biol Pharm Bull 1996; 19 (3): 444-8. Go to original source... Go to PubMed...
    13. Paul E, Conant KD, Dunne IE, Pfeifer HH, Lyczkowski DA, Linshaw MA, Thiele EA. Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res 2010; 90(1-2): 151-156. Go to original source... Go to PubMed...
    14. Rosati A., Bagul M., Giorgi L., Bradshaw K., Guerrini R. Impact of long-term treatment with adjunctive once-daily zonisamide on measures of growth and development in pediatric patients with partial epilepsy. Epilepsia 2013; 54(Suppl.3): 173.
    15. Ryzí M., Ošlejšková H. Zonisamid - použití v dětství a adolescenci. Neurol.praxi; 14(Suppl.A): A13.
    16. Sackellares JC, Ramsay RE, Wilder BJ, Browne TR 3rd, Shellenberger MK. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 2004; 45(6): 610-617. Go to original source... Go to PubMed...
    17. Sills G, Brodie M. Pharmacokinetics and drug interactions with zonisamide. Epilepsia 2007; 48(3): 435-441. Go to original source... Go to PubMed...
    18. Shinnar S, Pellock JM, Conry JA. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Eur J Paediatr Neurol 2009; 13(1): 3-9.. Go to original source... Go to PubMed...
    19. Schmidt D, Jacob R, Loiseau P, Deisenhammer E, Klinger D, Despland A, Egli M, Bauer G, Stenzel E, Blankenhorn V. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993; 15(1): 67-73. Go to original source... Go to PubMed...
    20. Schulze-Bonhage A. Zonisamide in the treatmentof epilepsy. Expert Opin Pharmacother 2010; 11(1): 115-126. Go to original source... Go to PubMed...
    21. Suzuki Y. Zonisamide in West syndrome. Brain Dev 2001; 23(7): 658-661. Go to original source... Go to PubMed...
    22. Yagi K. Overview of Japanese experience-controlled and uncontrolled trials. Seizure 2004; 13(Suppl1): S11-15. Go to original source... Go to PubMed...
    23. Yamatogi Y, Ohtahara S. Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases.Brain Dev 2002; 24(1): 13-23. Go to original source... Go to PubMed...
    24. You SJ, Kang HC, Kim HD, Lee HS, Ko TS. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience. Brain Dev 2008; 30(4): 287-290. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.